Johnson P J, Krasner N, Portmann B, Eddleston A L, Williams R
Gut. 1978 Nov;19(11):1022-6. doi: 10.1136/gut.19.11.1022.
An analysis of 294 patients who died with cirrhosis showed that 24% had developed hepatocellular carcinoma. Haemochromatosis and HBsAg positive chronic active hepatitis were high risk groups (36% and 42% respectively) and the frequency was lowest in primary biliary cirrhosis and HBsAg negative chronic active hepatitis (3% and 11% respectively). Those with hepatocellular carcinoma showed a striking male preponderance (11:1) and further analysis has shown that the proportion developing this tumour in each group was closely related to the proportion of males in that group (r=0.97). Age was the only other significant factor, malignant change occurring more commonly in those over the age of 50 years than those below (30% and 7% respectively, P less than 0.005). The indluence of HBsAg was largely accounted for by the known predisposition of males to carry HBsAg. The group of patients who had developed this tumour without cirrhosis were younger (mean age 39 years) and had a lower male to female ratio of 1.1:1 and the place of contraceptive-related tumour within this group is dicussed.
对294例死于肝硬化的患者进行分析发现,24%的患者已发生肝细胞癌。血色素沉着症和乙肝表面抗原阳性的慢性活动性肝炎是高危组(分别为36%和42%),而在原发性胆汁性肝硬化和乙肝表面抗原阴性的慢性活动性肝炎中发生率最低(分别为3%和11%)。患肝细胞癌的患者明显以男性居多(11:1),进一步分析表明,每组中发生该肿瘤的比例与该组男性的比例密切相关(r = 0.97)。年龄是另一个唯一的重要因素,恶性病变在50岁以上的人群中比50岁以下的人群中更常见(分别为30%和7%,P小于0.005)。乙肝表面抗原的影响在很大程度上是由于已知男性携带乙肝表面抗原的易感性。在没有肝硬化的情况下发生该肿瘤的患者组更年轻(平均年龄39岁),男女比例较低,为1.1:1,并讨论了与避孕相关肿瘤在该组中的位置。